Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the“Company ...

A week after one New Haven-based biotechnology company announced a mass layoff, another has announced plans to cut 40% of its ...

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Arvinas, Inc. (“Arvinas ...

Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. ("Arvinas" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...

Fintel reports that on May 5, 2025, Truist Securities downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Buy to Hold. Analyst Price Forecast Suggests 321.24% Upside As of April 24, 2025, the ...

Ratings for Arvinas (NASDAQ:ARVN) were provided by 25 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ...

Shares of Arvinas stock opened at $7.72 on Friday. The firm has a market capitalization of $563.49 million, a PE ratio of -2.79 and a beta of 2.21. The firm’s 50 day moving average is $9.66 and ...